by
John R. Fischer, Senior Reporter | May 26, 2023
Boston Scientific is investing 80 million Euros in expansions at its Clonmel facility in Ireland.
Massachusetts-based medical device company Boston Scientific has added 400 new positions, as part of an €80 million (over $86 million) investment in the expansion of its manufacturing and research and development capabilities at its Clonmel site in County Tipperary, Ireland.
The company, which designs medical devices for treating 400,000 patients globally each year, including for cardiac conditions, cancer, neurological disorders, kidney stones, and diseases of the pancreas, bile ducts, and esophagus, is adding more office and manufacturing space within the existing premises, with no extra buildings needed,
according to the Irish Times.
It also is switching to renewable sources for more than 90% of the facility’s energy needs, in line with its objective to make its manufacturing and key distribution sites carbon neutral by 2030.
It has already begun recruiting for the positions in a variety of areas, including in production, engineering, quality, supply chain, and R&D, planning to fill all of them within two years,
reports Tipperary Live.
“Our team has worked to build strong manufacturing and R&D capabilities and also a high-performing and inclusive culture that we are proud to continue to foster as an employer of choice,” said Conor Russell, Boston Scientific's vice president of operations.
Operating in the emerald isle since 1994, Boston Scientific is the largest life sciences employer in Ireland, employing more than 6,500 people in Clonmel, Galway, and Cork. The Clonmel site currently employs 1,200 people, according to Tipperary Live.
The company previously
invested €100 million (over $108 million) in April 2022 to expand its Ballybrit facility in Galway, adding 40,000 square feet of space for manufacturing medical devices, and saying that it would create more than 300 new jobs here in the coming years as part of this investment. This site too is powered by renewable energy and includes a carbon-neutral manufacturing space.
It also invested €26 million in R&D activities at its Clonmel site in 2011.
County Tipperary Chamber CEO Michelle Aylward told Tipperary Live that the number of hires associated with the investment, which she called “phenomenal,” will have a “tremendous” impact on the local economy in Clonmel.
Back to HCB News
